Statistics

Total Visits

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)79

Select a period of time:

Number of views in the range

Views
Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)26

Views

Views
September 20255
October 20256
November 20258
December 20254
January 20261
February 20260
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom8
Brazil8
United States3
Argentina2
Algeria1
Ecuador1
Mexico1
Paraguay1
Uruguay1
 

Top cities views

Views
Blumenau1
Contagem1
Des Moines1
Ghardaïa1
Goianésia1
Hurlingham1
Irapuato1
Joinville1
London1
Marabá1